Shanghai - Delayed Quote • CNY Topchoice Medical Co., Inc. (600763.SS) Follow Compare 41.54 +0.35 +(0.85%) At close: 3:00:04 PM GMT+8 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 600763.SS 1D 5D 0.12% 1M -11.28% 3M -21.15% 6M -3.84% YTD -9.32% 1Y -12.38% 5Y -43.24% All 1,369.83% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Related News View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market Softer Trump tariffs, crypto & AI orders, Boeing: 3 Things Verizon Fourth-Quarter Results Top Views Amid Double-Digit Postpaid Subscriber Growth Mark Cuban's Black Amex Card Got Declined Buying A $140,000 Bottle Of Champagne To Celebrate Team's NBA Win – 'Can I Please Spend Some Money?' Meta to invest up to $65 billion in capital expenditure this year American Express Q4 Earnings: Revenue Beat, Record Spending and Card Acquisitions, 17% Dividend Hike And More Verizon Communications (NYSE:VZ) Will Be Hoping To Turn Its Returns On Capital Around Update: Market Chatter: Meta Platforms Faces Urgent AI Glitch Over Incorrect President Identification Stocks to watch next week: ASML, Intel, LVMH, Shell and Glencore 3 Richly Valued Stocks I'll Be Watching Like a Hawk in 2025 Novo Nordisk stock pops on Phase 1 data for new weight loss drug amycretin